| Mrs Jennifer D Short, LCSW-C | |
|
29520 Canvasback Dr, Easton, MD 21601-7124 | |
| (410) 822-5007 | |
| (410) 822-5569 |
| Full Name | Mrs Jennifer D Short |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 20 Years |
| Location | 29520 Canvasback Dr, Easton, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275603144 | NPI | - | NPPES |
| 517251 | Other | UHC MAMSI | |
| 259147000 | Other | MAGELLAN GROUP | |
| 522156095 | Other | MD | AMERICAN PSYCH SYSTEM |
| LM49EA | Other | MD | CAREFIRST BCBS |
| 609500300 | Medicaid | MD | |
| 609550004 | Medicaid | MD | |
| 609500301 | Medicaid | MD | |
| 609550001 | Medicaid | MD | |
| 609550002 | Medicaid | MD | |
| R968 | Other | CAREFIRST FEDERAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 14903 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peace Of Mind Mental Health Services Llc | 6103047436 | 11 |
News Archive
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.
Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.
› Verified 6 days ago
| Entity Name | Peace Of Mind Mental Health Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952715161 PECOS PAC ID: 6103047436 Enrollment ID: O20141029002314 |
News Archive
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.
Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer D Short, LCSW-C 2336 Goddard Parkway, Salisbury, MD 21801 Ph: (410) 334-6961 | Mrs Jennifer D Short, LCSW-C 29520 Canvasback Dr, Easton, MD 21601-7124 Ph: (410) 822-5007 |
News Archive
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.
Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.
› Verified 6 days ago
Paul J Washo, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 29520 Canvasback Dr, Easton, MD 21601 Phone: 410-822-5007 | |
Ms. Christina P Morris, LICENSED CLINICAL SO Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Talbot St, Easton, MD 21601 Phone: 410-822-1018 Fax: 410-820-5884 | |
Jennifer L Fitzpatrick, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Talbot Street, Easton, MD 21601 Phone: 410-822-1018 Fax: 410-820-5884 | |
Elizabeth Chatham, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 300 Talbot St, Easton, MD 21601 Phone: 410-822-1018 | |
Kira Ashley Gillin, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29512 Canvasback Dr, Easton, MD 21601 Phone: 630-835-6550 | |
Emma Ikharo, LCPC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29466 Pintail Dr, Ste 9, Easton, MD 21601 Phone: 410-770-5140 Fax: 410-770-5141 | |
Norma L. Trax, MED, MSW, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8571 Black Dog Aly, Easton, MD 21601 Phone: 410-991-3395 |